Luoda has invented, patented, developed, registered and manufactured a novel oral liquid formulation of pimobendan to improve ease and reliability of administration, compliance and effectiveness.
Congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation) in dogs.
|Development Status:||Registration submitted|
|Licence Status:||Partner / funding secured|
|Commercialisation Date:||November 2016|